Listed

Flexible Solutions International Inc: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 14, 2025 and accepted by EDGAR at Nov 14, 2025, 21:31 ET.

Share

Management's discussion and analysis

As filed, 7,626 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

The Company manufactures and markets biodegradable polymers which are used in the oil, gas and agriculture industries. The Company also develops, manufactures and markets specialty chemicals that slow the evaporation of water.

Results of Operations

We have three product lines.

The first is a chemical used in swimming pools and spas. The product forms a thin, transparent layer on the water’s surface. The transparent layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period of time thereby reducing the energy required to maintain the desired temperature of the water. A modified version can also be used in reservoirs, potable water storage tanks, livestock watering pods, canals, and irrigation ditches for the purpose of reducing evaporation. These products are sold by our EWCP division.

The second product, biodegradable polymers (“TPAs”), is used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping. TPAs can also be used to increase biodegradability in detergents and in the agriculture industry to increase crop yields by enhancing fertilizer uptake. TPA’s are sold by our BCPA division.

The third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen fertilizer after initial application and allow less fertilizer to be used. These products are made and sold by the Company’s BCPA division.

From time to time, the BCPA division also engages in performing research and development services for third parties.

Material changes in the Company’s Statement of Operations and Comprehensive Income (Loss) for nine and three months ended September 30, 2025 compared to the same period in the prior year are discussed below:

Three Months ended September 30, 2025

Item Increase (I) or Decrease (D) Reason
Sales
EWCP products D Decreased customer orders.
TPA products I Increased customer orders.
Gross profit as a percentage of sales D Increased costs associated with scaling up new products.

20

Consulting D Decreased reliance on consultants.
Office and miscellaneous I Increase related to building repair and maintenance.
Professional fees I Increase in accounting fees related to tax filings and increase in audit fees related to growth of the Company.
Research and development I New product development.
Utilities I Increase related to increase in production hours.
Gain on investment D Sale of 30.1% of Florida based LLC in 2024 reduced our Company’s portion of the profits.
Loss on sale of investment D One time loss on the sale of 30.1 % of Florida based LLC in 2024.
Interest income I Increased interest rates.

Nine Months ended September 30, 2025

Item Increase (I) or Decrease (D) Reason
Sales
EWCP products D Decreased customer orders.
TPA products D Decreased customer orders.
Research and development services I Due to a successful project that completed in 2025.
Advertising and promotion I Increase in marketing.
Consulting D Decreased reliance on consultants.
Office and miscellaneous I Increase related to building repair and maintenance.
Professional fees I Increase in accounting fees related to tax filings and increase in audit fees related to growth of the Company.
Research and development I New product development.
Travel D Travel requirements were lower for the first nine months in 2025 than in 2024.

21

Utilities I Increase related to increase in production hours.
Gain on investment D Sale of 30.1% of Florida based LLC in 2024 reduced our Company’s portion of the profits.
Loss on sale of investment D One time loss on the sale of 30.1 % of Florida based LLC in 2024.
Interest expense I Increase of interest rate on one of the mortgages.

Three customers accounted for 65% of our product sales during the three months ended September 30, 2025 (2024 –60%) and 54% of our product sales during the nine months ended September 30, 2025 (2024 – 52%). The amount of revenue (all from the sale of TPA products) attributable to each customer is shown below. Research and development services sales are not included in product sales

Customer Three months ended September 30, 2025 2024 Nine months ended September 30, 2025 2024
Company A $5,116,815 $2,812,736 $7,041,541 $5,238,881
Company B $1,253,034 $1,794,262 $5,181,609 $6,606,882
Company C $411,435 * $942,752 $2,230,577 $3,399,619
Company D $501,676 $- $982,517 * $742,429 *

*not a primary customer in that period

Customers with balances greater than 10% of our receivables as of September 30, 2025 and 2024 are shown below:

September 30, 2025 2024
Company A $4,898,789 $2,571,320
Company B $1,557,505 $1,434,835

Other factors that will most significantly affect future operating results will be:

  • the sale price of crude oil which is used in the manufacture of aspartic acid we import from China. Aspartic acid is a key ingredient in our TPA products;
  • activity in the oil and gas industry, as we sell our TPA products to oil and gas companies;
  • drought conditions, since we also sell our TPA products to farmers; and
  • new tariffs relating to raw materials imported from China.

Other than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material impact on our revenues or expenses.

Capital Resources and Liquidity

The Company’s sources and (uses) of cash for the nine months ended September 30, 2025 and 2024 are shown below:

2025 2024
Cash provided by operating activities 6,757,198 7,787,989
Net purchases (maturities) of term deposits 1,014,766 319,916
Purchase of property and equipment (3,310,168) (2,876,119)
Return of investment 500,000 -
Distributions received from equity investments - 430,402
Proceeds from sale of investment - 2,000,000
Repayment of short term lines of credit, net (1,495,046) (1,810,479)
Repayment of long term debt (1,680,304) (917,692)
Proceeds from long term debt - 2,162,412
Dividends paid (1,274,753) (1,255,053)
Distributions to non-controlling interest (329,635) (365,644)
Proceeds from shares issued upon exercise of stock options 467,030 26,250
Effect of exchange rate change on cash 201,509 100,276

The Company has sufficient cash resources to meets its future commitments and cash flow requirements for the coming year. As of September 30, 2025, working capital was $21,780,752 (December 31, 2024 - $22,714,190) and the Company has no substantial commitments that require significant outlays of cash over the coming fiscal year.

Other than as disclosed above, the Company does not anticipate any capital requirements for the twelve months ending September 30, 2026.

Other than as disclosed above, the Company does not know of any trends, demands, commitments, events or uncertainties that will result in, or that are reasonable likely to result in, its liquidity increasing or decreasing in any material way.

Controls and procedures

As filed, 1,709 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Under the direction and with the participation of our management, including our Principal Executive and Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2025. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and regulations, and that such information is accumulated and communicated to our management, including our principal executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching desired disclosure control objectives. Based on the evaluation, our Principal Executive and Financial Officer concluded that these disclosure controls and procedures are effective as of September 30, 2025

Changes in Internal Control over Financial Reporting

Our management, with the participation of our Principal Executive and Financial Officer, evaluated whether any change in our internal control over financial reporting occurred during the three months ended September 30, 2025. Based on that evaluation, it was concluded that there has been no change in our internal control over financial reporting during the three months ended September 30, 2025 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-07-01 to 2025-09-30$10.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2025-01-01 to 2025-09-30$29.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2025-07-01 to 2025-09-30$8.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2025-01-01 to 2025-09-30$19.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2025-07-01 to 2025-09-30$2.5mus-gaap:GrossProfit
Gross profit9 months2025-01-01 to 2025-09-30$9.9mus-gaap:GrossProfit
Research and development3 months2025-07-01 to 2025-09-30$255.7kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2025-01-01 to 2025-09-30$529.7kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2025-07-01 to 2025-09-30$311.3kus-gaap:OperatingIncomeLoss
Operating income9 months2025-01-01 to 2025-09-30$3.5mus-gaap:OperatingIncomeLoss
Income tax3 months2025-07-01 to 2025-09-30−$181.7kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2025-01-01 to 2025-09-30$944.8kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-07-01 to 2025-09-30−$503.4kus-gaap:NetIncomeLoss
Net income9 months2025-01-01 to 2025-09-30$1.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-07-01 to 2025-09-30−$0.04us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2025-01-01 to 2025-09-30$0.09us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30−$0.04us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-01-01 to 2025-09-30$0.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-3012,660,923 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2025-01-01 to 2025-09-3013,524,716 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-01-01 to 2025-09-30$6.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2025-01-01 to 2025-09-30$3.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2025-01-01 to 2025-09-30$1.3mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2025-09-30$8.5mus-gaap:Cash
Current assetsAt period end2025-09-30$32.9mus-gaap:AssetsCurrent
Total assetsAt period end2025-09-30$58.4mus-gaap:Assets
Current liabilitiesAt period end2025-09-30$11.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-09-30$15.4mus-gaap:Liabilities
Long-term debtAt period end2025-09-30$4.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2025-09-30$2.9mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2025-09-30$39.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-25-023546. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.